| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Rambam Health Care Campus |
| Information provided by: | Rambam Health Care Campus |
| ClinicalTrials.gov Identifier: | NCT00416065 |
Purpose
The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the presence of arterial calcifications as seen on the simultaneously acquired CT, in order to determine if FDG was increases incalcified plaque or in a different location in the arterial wall. we will also evaluate the relationship between FDG localization and future cardiovascular events in out patient population
| Condition | Intervention |
|
Cancer |
Device: PET/CT imaging |
| Study Type: | Interventional |
| Study Design: | Randomized, Open Label, Uncontrolled, Single Group Assignment |
| Official Title: | PET/CT to Identify "Vulnerable" Arterial Plaque |
Eligibility
| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Ora Israel, MD | 972-4-8543009 | o_israel@rambam.health.gov.il |
| Israel | |||||
| Rambam Medical Center | Recruiting | ||||
| Haifa, Israel | |||||
| Contact: Ora Israel, MD 972-4-8543009 o_israel@rambam.health.gov.il | |||||
| Rambam Health Care Campus |
| Principal Investigator: | Ora Israel, MD | Rambam Health Care Campus |
More Information
| Study ID Numbers: | plaqueCTIL |
| First Received: | December 26, 2006 |
| Last Updated: | December 26, 2006 |
| ClinicalTrials.gov Identifier: | NCT00416065 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
